$PGNX Company News Progenics prices offering at 5.2%

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2014 at 11:42 AM

$PGNX Company News

Progenics prices offering at 5.2% discount 12:02 p.m. Nov. 29, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Drug stocks up as OSI rejects $3.5 billion bid 4:32 p.m. March 15, 2010 - Kate Gibson
Wyeth, Progenics: Phase 3 trial of Relistor misses endpoints 7:05 a.m. May 22, 2008 - Michelle Donley
Wyeth, Progenics get Canadian approval for Relistor 7:09 a.m. April 1, 2008 - Michael Kitchen
Monday's biggest gaining and declining stocks 2:07 p.m. March 17, 2008 - MarketWatch
U.S. stocks close lower as record high crude weighs 4:38 p.m. March 12, 2008 - Nick Godt
Drug stocks gain; Progenics plunges on failed study 3:46 p.m. March 12, 2008 - Val Brickates Kennedy
U.S. stock futures steady to lower after big run-up 9:16 a.m. March 12, 2008 - Steve Goldstein
Wyeth delayed on trade errors; Momenta shares slump 1:13 p.m. June 28, 2007 - Val Brickates Kennedy
Progenics, Wyeth report positive methylnaltrexone study 5:10 a.m. June 28, 2007 - Steve Goldstein
Progenics, Wyeth say 'positive' Methylnaltrexone study 5:07 a.m. June 28, 2007 - Steve Goldstein
Biotech, pharma rise; Vertex slips on earnings 12:01 p.m. May 1, 2007 - Val Brickates Kennedy
Progenics, Wyeth submit NDA for methylnaltrexone formula 5:08 a.m. March 30, 2007 - Sarah Turner
Progenics, Wyeth to submit NDA for methylnaltrexone formula 5:01 a.m. March 30, 2007 - Sarah Turner
U.S. markets poised to retest major support 10:14 a.m. March 14, 2007 - Michael Ashbaugh
Biotech, pharma benchmarks fall; CV Therapeutics dives 5:18 p.m. March 7, 2007 - Val Brickates Kennedy

What Does A Positive Adcom Mean For Progenics And Salix? 1:54 p.m. June 17, 2014 - Seeking Alpha
$5 Or Less: 3 Small, Speculative Biotechs On The Move 1:41 p.m. June 17, 2014 - Seeking Alpha
Two Undervalued Biopharmas to Buy Now 10:55 a.m. June 16, 2014 - Barrons.com
Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% - Tale of the Tape 8:44 a.m. June 13, 2014 - Zacks.com
Progenics schedules conference call to discuss Ad Comm recommendation 6:06 p.m. June 12, 2014 - Seeking Alpha
Ad Comm recommendation bodes well for opioid-induced constipation drugs 12:54 p.m. June 12, 2014 - Seeking Alpha
Progenix trading halted while Ad Comm meets 8:28 a.m. June 11, 2014 - Seeking Alpha
Progenics Pharmaceuticals (PGNX) in Focus: Stock Falls 5.5% - Tale of the Tape 8:49 a.m. June 5, 2014 - Zacks.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11 Adcom 8:30 a.m. May 30, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Nektar Therapeutics: The Time Is Nigh 11:57 a.m. May 19, 2014 - Seeking Alpha
Progenics' Q1 Loss Narrows - Analyst Blog 11:10 a.m. May 15, 2014 - Zacks.com
Salix Q1 Earnings Boosted by Santarus Acquisition - Analyst Blog 1:41 p.m. May 9, 2014 - Zacks.com
Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q1 2014 Results - Earnings Call Transcript 12:31 p.m. May 9, 2014 - Seeking Alpha
10-Q: PROGENICS PHARMACEUTICALS INC 10:42 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Progenics Pharmaceuticals (PGNX) Q1 2014 Results - Earnings Call Webcast 8:25 a.m. May 9, 2014 - Seeking Alpha
Progenics Finishes Patient Enrollment - Analyst Blog 7:00 p.m. April 25, 2014 - Zacks.com
Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC 9:17 a.m. April 24, 2014 - benzinga.com
EMA considers Relistor label expansion 12:21 p.m. April 23, 2014 - Seeking Alpha

Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
Progenics Schedules Investor Conference Call Following FDA Advisory Committee 3:41 p.m. June 12, 2014 - GlobeNewswire
FDA Ad Comm Provides Recommendations Regarding the Potential Cardiovascular Risk Associated with the Class of Peripherally-active Opioid Receptor Antagonists and the Trials to Support Approval of Products for OIC 2:32 p.m. June 12, 2014 - BusinessWire - BZX
Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Consider and Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists 7:06 a.m. June 11, 2014 - GlobeNewswire
Technical Analysis on Biotech Equities -- Research on Incyte, Progenics Pharma, Immunomedics, and Arqule 7:30 a.m. June 5, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals CEO Mark Baker to Present at Jefferies Global Healthcare Conference 2:31 p.m. June 2, 2014 - GlobeNewswire
Progenics Pharmaceuticals' PSMA ADC Data Selected for Poster Highlight Presentation at ASCO 2014 8:01 a.m. May 30, 2014 - GlobeNewswire
Stocks Analysis on Top Gainers -- Research on Progenics Pharma, Lionbridge Technologies, Nuverra Environmental Solutions, and Senomyx 11:30 a.m. May 12, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces First Quarter 2014 Financial Results 7:31 a.m. May 9, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets First Quarter 2014 Financial Results Call for May 9 7:31 a.m. May 1, 2014 - GlobeNewswire
Earnings Schedules, Acquisition Agreements, and Financial Results Release - Analyst Notes on Mallinckrodt, BioMarin, Salix Pharmaceuticals, St. Jude Medical and Quest Diagnostics 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces the Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC 10:18 a.m. April 24, 2014 - GlobeNewswire
Salix Pharmaceuticals and Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand the Use of RELISTOR in Chronic Non-Cancer Pain by the European Medicines Agency 7:02 a.m. April 22, 2014 - BusinessWire - BZX
Progenics Pharmaceuticals and Centre for Probe Development and Commercialization Announce Agreement to Manufacture Targeted Radiotherapeutic Candidate for Ultra-Orphan Indications 12:36 p.m. April 1, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Top Gainers Ahead of Market -- Research on Genco Shipping & Trading, Progenics Pharma, Rambus, and Exact Sciences 8:05 a.m. March 19, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2013 Financial Results and Initiates Clinical Development of Small Molecule Targeted Therapeutic 9:02 a.m. March 13, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets 4Q and Year-End 2013 Financial Results Call for March 13 1:48 p.m. March 10, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets 1Q 2014 Financial Results Call for March 13 1:00 p.m. March 4, 2014 - GlobeNewswire
DryShips Braces for More Losses in Slowly Recovering Economy 10:34 a.m. Feb. 24, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...